Jane Gross
Direttore/Membro del Consiglio presso ATYR PHARMA, INC.
Patrimonio netto: 9 360 $ in data 30/06/2024
Posizioni attive di Jane Gross
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ATYR PHARMA, INC. | Direttore/Membro del Consiglio | 28/06/2019 | - |
| Independent Dir/Board Member | 28/06/2019 | - | |
| BRIACELL THERAPEUTICS CORP. | Direttore/Membro del Consiglio | 01/11/2021 | - |
| Independent Dir/Board Member | 01/11/2021 | - | |
| Washington Biotechnology & Biomedical Association | Direttore/Membro del Consiglio | - | - |
BriaPro Therapeutics Corp.
 BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Direttore/Membro del Consiglio | - | - |
| Independent Dir/Board Member | - | - |
Storia della carriera di Jane Gross
Precedenti posizioni note di Jane Gross
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2016 | 14/09/2021 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/07/2011 | 01/08/2016 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/02/2009 | 01/06/2010 |
Formazione di Jane Gross
| University of California, Berkeley | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Canada | 3 |
Posizioni
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| APTEVO THERAPEUTICS INC. | Health Technology |
| ATYR PHARMA, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Aziende private | 3 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Jane Gross
- Esperienza
